Global framework for biosimilars "is now crucial"

Article Date: 25/04/2012 06:00
Global framework for biosimilars "is now crucial"

Vacancy Search

Quick job search

Advanced Search

Latest News

Ablynx signs RA deal with China's Eddingpharm

Ablynx signs RA deal with China's Eddingpharm

Europe: heart disease, stroke declining, but more people in hospital

Europe: heart disease, stroke declining, but more people in hospital

UK cancer death rate for children drops 22% in a decade

UK cancer death rate for children drops 22% in a decade

FDA approves UCB's Vimpat as monotherapy

FDA approves UCB's Vimpat as monotherapy

Sanofi/Regeneron's alirocumab reduces CV events in trial

Sanofi/Regeneron's alirocumab reduces CV events in trial

Long-term data show no cancer risk from Takeda/Lilly's Actos

Long-term data show no cancer risk from Takeda/Lilly's Actos

Doctors make urgent call for child obesity task force

Doctors make urgent call for child obesity task force

Novartis heart failure drug set to revolutionise treatment

Novartis heart failure drug set to revolutionise treatment

UK CVD costs to reach €23.1 billion by 2020: study

UK CVD costs to reach €23.1 billion by 2020: study

Ipsen pleased with solid first half performance

Ipsen pleased with solid first half performance
more news